Home › Funds › Lynx1 Capital Management LP › PRQR

Lynx1 Capital Management LP position in PRQR

PROQR THRAPEUTICS N V · Health Care

Lynx1 Capital Management LP reported holding 521,413 shares of PRQR (PROQR THRAPEUTICS N V) in its Q2 2026 13F filing — a position valued at US$970K, representing 0.11% of its reported portfolio and ranking #15 among its reported holdings. Lynx1 Capital Management LP has disclosed PRQR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)521.41K sh
Reported value held$969.83K
Portfolio Weight0.11%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Lynx1 Capital Management LP's PRQR position evolved

Lynx1 Capital Management LP first disclosed a stake in PRQR in Q4 2025 at 68,486 shares (US$138K). The position peaked in Q2 2026 at 521,413 shares, worth US$970K. Across 3 filings, Lynx1 Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 521,413 shares valued at US$970K — an increase of 452,927 shares quarter over quarter.. Notable position changes include a 661% increase in Q2 2026 (shares fell 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 68.49K $138.34K New
Q1 2026 68.49K $110.95K Hold
Q2 2026 521.41K $969.83K Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRQR and 13F data

PRQR (PROQR THRAPEUTICS N V) is a Health Care company. 35 other funds we track also report a position in PRQR — the largest reported positions include Privium Fund Management B.V. (US$10.3M), Ikarian Capital, LLC (US$6.4M), HEIGHTS CAPITAL MANAGEMENT, INC (US$5.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRQR

All PRQR fund holders →

FAQ

How long has Lynx1 Capital Management LP held PRQR?

Lynx1 Capital Management LP has disclosed PRQR holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Lynx1 Capital Management LP's current position in PRQR?

As of Q2 2026, Lynx1 Capital Management LP holds 521.41K shares of PRQR (PROQR THRAPEUTICS N V), valued at $969.83K, representing 0.11% of its reported portfolio and ranking #15.

Has Lynx1 Capital Management LP been buying or selling PRQR?

In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP increased its position in PRQR. The position peaked in Q2 2026 at 521.41K shares.

Which other funds hold PRQR?

Other major institutional holders of PRQR include Privium Fund Management B.V., Ikarian Capital, LLC, HEIGHTS CAPITAL MANAGEMENT, INC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.